Regulation of cyclooxygenase expression by vasopressin in rat renal medulla.
Ming-Zhi Zhang, Pedro Sanchez Lopez, James A McKanna, Raymond C Harris
Index: Endocrinology 145(3) , 1402-9, (2004)
Full Text: HTML
Abstract
The antagonism between prostaglandin and vasopressin represents a classic negative feedback loop. It is not clear whether cyclooxygenase (COX)-2 and/or COX-1 expression is involved in elevated prostaglandin production stimulated by vasopressin in vivo. In the present study, we explored vasopressin regulation of medullary COX-2 and COX-1 expression acutely and chronically in rats. Medullary COX-1 expression was moderately lower and COX-2 expression was significantly lower in adult male Brattleboro rats than age-matched Long-Evans controls. Chronic treatment of Brattleboro rats with vasopressin for 1 wk led to a decrease in urine volume and a moderate increase in medullary COX-1; in contrast, medullary COX-2 expression was almost undetectable in untreated rats but was dramatically up-regulated with vasopressin treatment and was accompanied by increased urinary prostaglandin E(2) excretion. Further investigation revealed that both V1 and V2 receptors were involved in chronic medullary COX-1 and COX-2 up-regulation. Acute treatment with specific V1 or V2 receptor agonists resulted in specific increases in medullary COX-2, which was prevented by furosemide. Vasopressin did not affect COX-2 expression in cultured renomedullary interstitial cells. These data demonstrate that vasopressin stimulates medullary COX-2 expression through activation of both V1 and V2 receptors, and this stimulation is indirect and probably involves increased medullary electrolyte tonicity.
Related Compounds
Related Articles:
1989-02-16
[Nature 337(6208) , 648-51, (1989)]
Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study.
2003-05-13
[Circulation 107(18) , 2313-9, (2003)]
A potent new synthetic analog of vasopressin with relative agonist specificity for the pituitary.
1991-08-01
[Endocrinology 129 , 1107-1109, (1991)]
Gastrointestinal absorption and plasma clearance rates of [D-Arg8]vasopressin analogues in the rat.
1994-01-01
[Peptides 15 , 809, (1994)]
Structure--function studies of vasopressin analogues with D-3 pyridyl-alanine in position 2.
1995-01-01
[Peptides 16 , 389-393, (1995)]